Skip to main content
. 2021 Nov 24;47(1):21. doi: 10.3892/or.2021.8232

Figure 1.

Figure 1.

FGD5-AS1 expression is increased in pancreatic cancer. (A) Online bioinformatics analysis tool (GEPIA) was utilized for analyzing FGD5-AS1 expression in pancreatic cancer and normal tissues. (B) RT-qPCR was utilized for detecting FGD5-AS1 expression in collected pancreatic cancer tissues and adjacent tissue samples (n=37). (C) RT-qPCR was employed for detecting FGD5-AS1 expression in pancreatic cancer cell lines (SW1990, PANC-1, CAPAN-1 and BXPC-3) and normal pancreatic ductal epithelial cells (HPDE6-C7). All of the experiments were performed in triplicate. *P<0.05 and ***P<0.001. FGD5-AS1, FGD5 antisense RNA 1; RT-qPCR, reverse transcription-quantitative PCR.